A Three-Year Multiphase Pressure Ulcer Prevalence/Incidence Study in a Regional Referral Hospital
- Wed, 9/3/08 - 10:25am
- 1 Comments
- 9365 reads
A pressure ulcer is any lesion caused by pressure resulting in damage of underlying tissue.1 At least 3 million adults in the US are reported to have pressure ulcers yearly.2 Pressure ulcers can have a devastating impact on health and care provision, ranging from patient discomfort to increased healthcare costs. Conservative cost estimates of caring for a patient with a pressure ulcer range from $500 to $50,000.3 The average hospital incurs $400,000 to $700,000 annually in direct costs to treat pressure ulcers.4
Nosocomial pressure ulcers in hospitals are one indicator for quality of care. The key to successful outcomes is early assessment and interventions to prevent or reduce their incidence.5 Baseline and ongoing prevalence and incidence studies can help achieve the desired outcomes and measure the effectiveness of interventions implemented in pursuit of those outcomes.
Prevalence is defined as the proportion of a group that has a pressure ulcer at a given time, which may be a single point in time or a time period during which the cases are counted. Incidence is the proportion of the group initially free of pressure ulcers that develop them during a specified period of study.6
The cornerstone of pressure ulcer prevention is identifying and minimizing risk factors with the use of a validated risk assessment tool such as the Braden Scale. The AHRQ Pressure Ulcer Prediction and Prevention Guidelines list several other recommendations related to maintaining tissue tolerance to pressure. Among these recommendations are the use of mild cleansing agents to minimize dryness and treating dry skin with moisturizers.5 Healthcare agencies that implement focused skin care protocols to prevent pressure ulcers and intervene as early as possible have been able to demonstrate reductions in the prevalence and incidence of pressure ulcers.7,8
Skin Physiology and Related Care
Determining who is at risk for pressure ulcer development requires some understanding of the physiology of the skin. The largest organ, the skin is the dividing line between an individual and the environment. The skin protects against infectious micro-organisms, ultraviolet light, noxious substances, and excess fluid electrolyte loss and is instrumental in thermoregulation, sensation, metabolism, and communication.9 The skin’s protective function is a complex process involving the acid mantle (pH 4.5 to 6), normal skin flora, and lipid barrier (sebum and extracellular lipids located in the cell layers of the stratum corneum). The stratum corneum (horny layer) is continuously exposed to the outside environment, providing the first line of protection, and is a vital part of the body’s immune system.10 The acidic environment and normal flora (resident micro-organisms) reduce the chance for pathogens to invade, contributing to the body’s immune response.
The pH and surfactant system of a skin cleanser may influence the skin’s pH and lipid barrier. Washing with an alkaline soap can increase the pH of the skin and reduce the lipid barrier; therefore, a product with a pH of 4 to 7 and gentle surfactant system is recommended for skin cleansing. This is particularly important for the elderly patient population, whose skin is dryer, more prone to cracking, and slower to recover from the effects of alkaline substances.11 In addition, the act of cleansing involves friction, which further insults the stratum corneum. Dry stratum corneum and friction are generally accepted as precursors to pressure ulcer development and can be partially offset by using moisturizers to facilitate stratum corneum hydration.5,12-14
1. Bryant RA. Skin pathology and types of skin damage. In: Bryant RA, ed.: Acute and Chronic Wounds: Nursing Management. Second Edition, St. Louis, Mo.: Mosby, Inc.;2000:144–145.
2. Eckman KL. The prevalence of dermal ulcers among persons in the US who have died. Decubitus. 1989;2:36–40.
3. Lyder CH, Yu C, Emerling J, Empleo-Frazier O, Mangat R, Stevenson D, et al. The Braden scale for pressure ulcer risk: evaluating the predictive validity in black and Latino/Hispanic elders. Appl Res. 1999;12:60–68.
4. Robinson C, Gloekner M, Bush S, et al. Determining the efficacy of a pressure ulcer prevention program by collecting prevalence and incidence data: a unit-based report, Ostomy Wound Manage. 2003;49(5)44–51.
5. Panel for the Prediction and Prevention of Pressure Ulcers in Adults. Clinical Practice Guideline Number 3: Pressure Ulcers in Adults: Prediction and Prevention. Rockville, Md: US Department of Health and Human Services. Public Health Service. Agency for Health Care Policy and Research; 1992. AHCPR Publication 92-0047.
6. Houghton PE, Woodbury GM. The extent of chronic wounds in Canada. Wound Care Canada. 2003;1(1):30.
7. Langemo DK, Anderson J, Volden C. Nursing quality outcome indicators: the North Dakota study. J Nurs Adm. 2002;32:98–110.
8. Lyder CH, Shannon R, Empleo-Frazier O, McGeHee D, White C. A comprehensive program to prevent pressure ulcers in long-term care: exploring costs and outcomes. Ostomy Wound Manage. 2002; 48:52–62.
9. Sibbald RG, Campbell, K, Queen D. Intact skin - an integrity not to be lost. Ostomy Wound Manage. 2003;49(6):27–41
10. Lindberg B, Forslind B. The skin as a barrier. In: Lodén M, Maibach HI, eds. Dry Skin and Moisturizers, Chemistry and Function. Boca Raton, Fla.: CRC Press;2000:27–37.
11. Nix D. Factors to consider when selecting skin cleansing products. J WOCN. 2000;27:260-268.
12. Maklebust J, Sieggreen M. Pressure Ulcers: Guidelines for Prevention and Nursing Management. Springhouse, Pa.: Springhouse;1996.
13. Guideline for Prevention and Management of Pressure Ulcers. WOCN Clinical Practice Guideline Series. Glenview, Ill.: Wound, Ostomy, and Continence Nurses Society; 2003:14.
14. Klingman A. Introduction. In: Loden, M, Maibach H I. Dry Skin and Moisturizers Chemistry and Function. Boca Raton, Fla.: CRC Press, 2000:3.
15. Lyder C, Clemes-Lowrance C, Davis A, Sullivan L, Zucker A. A structured skin care regimen to prevent perineal dermatitis in the elderly. J ET Nurs. 1992;12:12–16.
16. Cooper P, Gray D. Comparison of two skin care regimes for incontinence. Br J Nurs. 2001;Mar;10(6 Suppl):S6,S8,S10 passim.
17. Lewis-Byers K, Thayer D, Kahl A, An evaluation of two incontinence skin care protocols in a long-term care setting. Ostomy Wound Manage. 2002;48(12):44–51.
18. Warshaw E, Nix D, Kula J, Markon CE. Clinical and cost effectiveness of a cleanser protectant lotion for treatment of perineal skin breakdown in low-risk patients with incontinence. Ostomy Wound Manage. 2002;48:44–51.
19. Brown DS, Sears M. Perineal dermatitis: a conceptual framework. Ostomy Wound Manage. 1993;39(7):20-2,24–25.
20. Nix D. Prevention and treatment of perineal skin breakdown. In: Milne C, Corbett L, Dubuc D, eds. Wound, Ostomy, and Continence Nursing Secrets. Philadelphia, Pa.: Hanley & Belfus, Inc.;2002:373–377.
21. Fiers S, Thayer D. Management of intractable incontinence. In: Dougherty DB. Urinary and Fecal Incontinence: Nursing Management, 2nd ed. St. Louis, Mo.: Mosby; 2000:183–207.
22. Bergstrom N, Braden B. A conceptual schema for the study of the etiology of pressure sores. Rehabilitation Nursing. 1987;12(1):8B12.
23. Kuzma J, Bohnenblust S. Basic Statistics for the Health Sciences, 4th ed. Mountain View, Calif.: Mayfield Publishing Company;2001.
24. Hunter S, Anderson J, Hanson D, Thompson P, Langemo D, Klug MG. Clinical trial of a prevention and treatment protocol for skin breakdown in two nursing homes. J Wound Ostomy Continence Nurs. 2003;30(5):250–258.






Very interesting article. I hope to carry out a research like this in Jamaica in the near future
Reply to this comment »Post new comment